Ronifibrate |
|
| Other names | 3-[(pyridin-3-yl)carbonyloxy]propyl 2-(4-chlorophenoxy)-2-methylpropanoate |
|---|
| ATC code | |
|---|
|
3-{[2-(4-chlorophenoxy)-2-methylpropanoyl]oxy}propyl nicotinate
|
| CAS Number | |
|---|
| PubChem CID | |
|---|
| ChemSpider | |
|---|
| UNII | |
|---|
| ChEMBL | |
|---|
| CompTox Dashboard (EPA) | |
|---|
|
| Formula | C19H20ClNO5 |
|---|
| Molar mass | 377.82 g·mol−1 |
|---|
| 3D model (JSmol) | |
|---|
O=C(OCCCOC(=O)C(Oc1ccc(Cl)cc1)(C)C)c2cccnc2
|
InChI=1S/C19H20ClNO5/c1-19(2,26-16-8-6-15(20)7-9-16)18(23)25-12-4-11-24-17(22)14-5-3-10-21-13-14/h3,5-10,13H,4,11-12H2,1-2H3 YKey:AYJVGKWCGIYEAK-UHFFFAOYSA-N Y
|
N Y (what is this?) (verify) |
Ronifibrate is a fibrate, a hypolipidemic agent. It is a combined ester of clofibric acid and niacin (nicotinic acid) with 1,3-propanediol. In the body, the ester is split to 1,3-propanediol and both acids which work in the same way, lowering lipids in blood.
References
|
|---|
| PPARαTooltip Peroxisome proliferator-activated receptor alpha |
- Antagonists: GW-6471
- MK-886
|
|---|
| PPARδTooltip Peroxisome proliferator-activated receptor delta |
- Antagonists: FH-535
- GSK-0660
- GSK-3787
|
|---|
| PPARγTooltip Peroxisome proliferator-activated receptor gamma |
- SPPARMsTooltip Selective PPARγ modulator: BADGE
- EPI-001
- INT-131
- MK-0533
- S26948
- Antagonists: FH-535
- GW-9662
- SR-202
- T-0070907
|
|---|
| Non-selective | |
|---|
- See also
- Receptor/signaling modulators
|